Physician profile
Sonela Blaceri
NPI 1942640347
$10,185.23
in general payments reported to CMS, 2019-2025
42 companies · $1,837 in 2025
The $1,837 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,717 · 2020: $609 · 2021: $817 · 2022: $1,405 · 2023: $1,615 · 2024: $2,185 · 2025: $1,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,637.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,344.90 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $1,187.85 | 2019 | |
| Abbott Laboratories | $1,062.66 | 2019-2023 | Pressurewire |
| Janssen Pharmaceuticals, INC | $797.85 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $766.25 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $506.62 | 2019-2025 | Wainua, Farxiga |
| Tactile Systems Technology INC | $458.82 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Stryker Corporation | $413.12 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Abiomed | $399.52 | 2022-2025 | Impella |
| Merck Sharp & Dohme LLC | $383.63 | 2021-2025 | Verquvo |
| Cardiovascular Systems INC. | $358.58 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $297.26 | 2021-2025 | |
| Novo Nordisk INC | $291.43 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $245.58 | 2022-2025 | Turbohawk, Symplicity G3, Onyx Frontier |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.36 | 2021-2025 | Jardiance |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonela Blaceri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.